Literature DB >> 22998478

Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

A Rangel1, B Race, J Striebel, B Chesebro.   

Abstract

AIMS: Prion diseases are characterized by brain deposits of misfolded aggregated protease-resistant prion protein (PrP), termed PrPres. In humans and animals, PrPres is found as either disorganized non-amyloid aggregates or organized amyloid fibrils. Both PrPres forms are found in extracellular spaces of the brain. Thus, both might block drainage of brain interstitial fluid (ISF). The present experiments studied whether ISF blockage occurred during amyloid and/or non-amyloid prion diseases.
METHODS: Various-sized fluorescein-labelled ISF tracers were stereotactically inoculated into the striatum of adult mice. At times from 5 min to 77 h, uninfected and scrapie-infected mice were compared. C57BL/10 mice expressing wild-type anchored PrP, which develop non-amyloid PrPres similar to humans with sporadic Creutzfeldt-Jakob disease, were compared with Tg44+/+ mice (transgenic mice secreting anchorless PrP) expressing anchorless PrP, which develop amyloid PrPres similar to certain human familial prion diseases.
RESULTS: In C57BL/10 mice, extensive non-amyloid PrPres aggregate deposition was not associated with abnormal clearance kinetics of tracers. In contrast, scrapie-infected Tg44+/+ mice showed blockage of tracer clearance and colocalization of tracer with perivascular PrPres amyloid.
CONCLUSIONS: As tracer localization and clearance was normal in infected C57BL/10 mice, ISF blockage was not an important pathogenic mechanism in this model. Therefore, ISF blockage is unlikely to be a problem in non-amyloid human prion diseases such as sporadic Creutzfeldt-Jakob disease. In contrast, partial ISF blockage appeared to be a possible pathogenic mechanism in Tg44+/+ mice. Thus this mechanism might also influence human amyloid prion diseases where expression of anchorless or mutated PrP results in perivascular amyloid PrPres deposition and cerebral amyloid angiopathy. Published 2012. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22998478      PMCID: PMC3567241          DOI: 10.1111/j.1365-2990.2012.01303.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  31 in total

Review 1.  Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.

Authors:  Martin Jeffrey; Gillian McGovern; Silvia Sisó; Lorenzo González
Journal:  Acta Neuropathol       Date:  2010-06-08       Impact factor: 17.088

2.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

Review 3.  Pathophysiology of the vascular wall and its relevance for cerebrovascular disorders in aged rodents.

Authors:  A Popa-Wagner; D Pirici; E B Petcu; L Mogoanta; A-M Buga; C L Rosen; R Leon; J Huber
Journal:  Curr Neurovasc Res       Date:  2010-08       Impact factor: 1.990

4.  Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Rebecca Rosenke; James F Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy.

Authors:  Cheryl A Hawkes; Wolfgang Härtig; Johannes Kacza; Reinhard Schliebs; Roy O Weller; James A Nicoll; Roxana O Carare
Journal:  Acta Neuropathol       Date:  2011-01-23       Impact factor: 17.088

Review 6.  Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

Authors:  Roy O Weller; Delphine Boche; James A R Nicoll
Journal:  Acta Neuropathol       Date:  2009-02-22       Impact factor: 17.088

7.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

8.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT.

Authors:  Yong-An Chung; Joo Hyun O; Jee-Young Kim; Ki-Jun Kim; Kook-Jin Ahn
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

Review 10.  Lymphatic drainage of the brain and the pathophysiology of neurological disease.

Authors:  Roy O Weller; Effie Djuanda; Hong-Yeen Yow; Roxana O Carare
Journal:  Acta Neuropathol       Date:  2008-11-11       Impact factor: 17.088

View more
  5 in total

1.  PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Authors:  Allison Kraus; Gregory J Raymond; Brent Race; Katrina J Campbell; Andrew G Hughson; Kelsie J Anson; Lynne D Raymond; Byron Caughey
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

2.  Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in Mice.

Authors:  Bruce Chesebro; James Striebel; Alejandra Rangel; Katie Phillips; Andrew Hughson; Byron Caughey; Brent Race
Journal:  MBio       Date:  2015-09-22       Impact factor: 7.867

3.  Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein.

Authors:  Alejandra Rangel; Brent Race; Katie Phillips; James Striebel; Nancy Kurtz; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2014-01-21       Impact factor: 7.801

4.  Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein.

Authors:  Alejandra Rangel; Brent Race; Mikael Klingeborn; James Striebel; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2013-06-19       Impact factor: 7.801

5.  Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion Strains.

Authors:  James A Carroll; James F Striebel; Alejandra Rangel; Tyson Woods; Katie Phillips; Karin E Peterson; Brent Race; Bruce Chesebro
Journal:  PLoS Pathog       Date:  2016-04-05       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.